Spero Therapeutics (SPRO) FCF Margin (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 603,520.00 |
| Dec 31, 2025 | -20,651.00 |
| Sep 30, 2025 | 44,483.00 |
| Jun 30, 2025 | -5,656.00 |
| Mar 31, 2025 | 921.00 |
| Dec 31, 2024 | -1.97 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | -38,161.00 |
| Mar 31, 2024 | 9,077.00 |
| Dec 31, 2023 | -732,715.00 |
| Sep 30, 2023 | 798,396.00 |
| Jun 30, 2023 | 508,017.00 |
| Mar 31, 2023 | -602,885.00 |
| Dec 31, 2022 | 31,288.00 |
| Sep 30, 2022 | 110,799.00 |
| Jun 30, 2022 | 20,839.00 |
| Mar 31, 2022 | -118,723.00 |
| Dec 31, 2021 | 52,258.00 |
| Sep 30, 2021 | 8,722.00 |
| Jun 30, 2021 | -57,462.00 |
| Sep 30, 2020 | -5.46 Mn |
| Jun 30, 2020 | -6,631.00 |
| Mar 31, 2020 | 113,766.00 |
| Dec 31, 2019 | -230,539.00 |
| Sep 30, 2019 | 1.79 Mn |
| Jun 30, 2019 | -1.80 Mn |
| Mar 31, 2019 | 65,771.00 |
| Dec 31, 2018 | 3,770.00 |
| Sep 30, 2018 | 102,831.00 |
| Dec 31, 2017 | 47,843.00 |
| Sep 30, 2017 | 180,375.00 |
| Jun 30, 2017 | 141,994.00 |
| Mar 31, 2017 | -1.95 Mn |